TOPAS Advanced Polymers
Polyplastics
Americas: +1 248 479 8928  Asia: +81 03 6711 8610
Europe, ME, Africa: +49 1805-1-86727

 

Polyplastics to Showcase DURACON® POM PM Series at Upcoming Medical/Healthcare Trade Exhibitions

TOKYO, January 9, 2020 – The Polyplastics Group will showcase its latest material offering for the medical/healthcare market – DURACON® polyoxymethylene (POM) PM series for drug contact and delivery applications – at the Pharmapack exhibition in Paris, France (Stand #H72), February 5-6, and MD&M West in Anaheim, Calif., U.S. (Booth #440), February 11-13. The company will also feature the latest for its TOPAS® cyclic olefin copolymer (COC), a high-purity material for a range of medical applications which complements the PM series.

Medical items suitable for Duracon PM

In a changing and growing marketplace, medical device manufacturers and end users demand high-quality materials and reliable suppliers, according to Polyplastics, the world's leading global manufacturer of POM materials for diverse end-use markets. The first grade under the PM Series, DURACON POM PM09S01N, is finding growing acceptance in the market by delivering global medical and food regulatory compliance including ISO10993 and USP Class VI biocompatibility/cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food-contact 21 CFR 177.2470.

This polyacetal resin grade adheres to strict quality management systems including conformity to the VDI 2017 medical-grade plastics guideline. It also provides full traceability of processes and products, and production management based on GMP principles. Polyplastics also provides uniform quality and global supply.

Polyplastics offers medical device manufacturers extensive data on the long- term reliability of its materials. Customized data on extraction, moldability, durability, slip and wear, and other key attributes is also available.

TOPAS® COC is a glass-clear and highly pure plastic which offers stiffness and barrier resistance, biocompatibility, and drug compatibility for wearables, drug delivery, medical devices, pharmaceutical blisters and trays, and diagnostics and microfluidics.

For more information, visit https://www.polyplastics.com/en/docs/lp/201901_01/index.vm.

Press Contact: 
Joseph Grande
+1 413 684 2463

joe [at] jgrandecommunications.com

About TOPAS Advanced Polymers

TOPAS Advanced Polymers is the world’s leading maker of COC (cyclic olefin copolymer), a glass-clear and extremely pure plastic for healthcare, optics, packaging, and electronics applications. From insulin delivery, to food contact films, to tablet and smartphone components, TOPAS® COC is the high performance material of choice. The broad global regulatory compliance of TOPAS COC can make your next development a simpler task. 

TOPAS Advanced Polymers is a business of Polyplastics Co., Ltd., a global leader in the development and production of engineering thermoplastic solutions. The company’s broad product portfolio includes POM, PPS, PBT, and LCP plastics. The company has the largest global market share of POM. With more than 50 years of experience, the company is backed by a strong global network of R&D, production, and sales resources capable of creating advanced solutions for an ever-changing global marketplace.

TOPAS® is a registered trademark of TOPAS Advanced Polymers GmbH in Germany, the United States, and other countries for its family of cyclic olefin copolymer resins.